Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 1,540,000 | 1,511,000 | 1,617,000 | 1,615,000 | 1,600,000 |
| Cost of Goods | 342,000 | 343,000 | 357,000 | 344,000 | 328,000 |
| Gross Profit | 1,198,000 | 1,168,000 | 1,260,000 | 1,271,000 | 1,272,000 |
| Operating Expenses | 733,000 | 1,504,000 | 934,000 | 758,000 | 768,000 |
| Operating Income | 465,000 | -336,000 | 326,000 | 513,000 | 504,000 |
| Interest Expense | 32,000 | 21,000 | 14,000 | 23,000 | 20,000 |
| Other Income | 5,000 | 5,000 | -1,000 | 4,000 | -25,000 |
| Pre-tax Income | 438,000 | -352,000 | 311,000 | 494,000 | 459,000 |
| Income Tax | 104,000 | -83,000 | 106,000 | 136,000 | 162,000 |
| Net Income Continuous | 334,000 | -269,000 | 205,000 | 358,000 | 297,000 |
| Net Income | $334,000 | $-269,000 | $205,000 | $358,000 | $297,000 |
| EPS Basic Total Ops | 0.41 | -0.33 | 0.25 | 0.43 | 0.36 |
| EPS Basic Continuous Ops | 0.41 | -0.33 | 0.25 | 0.43 | 0.36 |
| EPS Diluted Total Ops | 0.42 | -0.33 | 0.24 | 0.42 | 0.35 |
| EPS Diluted Continuous Ops | 0.41 | -0.33 | 0.24 | 0.42 | 0.35 |
| EBITDA(a) | $465,000 | $-336,000 | $326,000 | $513,000 | $504,000 |